Inve India ▾
BLBLUEJET

Blue Jet Healthcare Q1 FY27 results (Apr–Jun 2026) and concall

Healthcare · Concall AI · Call held 3 Aug 2026

Blue Jet Healthcare Limited reported a strong Q1 FY27, with revenue from operations reaching INR293 crores and operating EBITDA margin improving to 33.5%. The PI segment drove growth, while strategic projects like Vizag and Hyderabad R&D are progressing well. However, gross margins faced pressure from rising raw material costs and product mix, and contrast media revenue saw a sequential decline due to transit delays, with INR30 crores deferred to the next quarter.

You’re reading a preview. Opening the full call uses 1 concall credit.

Sign in to use your monthly call allowance.

What they filed

Q1 FY27: revenue down 17.5%, net profit down 14.3% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue208 318 340 355 165 −21%192 −40%235 −31%293 −17%
EBITDA69 124 140 121 55 −20%47 −62%71 −49%98 −19%
Net profit58 99 110 91 52 −10%40 −60%64 −42%78 −14%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.